These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18924320)

  • 1. [Gastroesophageal diseases. Controversial issues].
    Vallot T
    Rev Prat; 2008 Sep; 58(13):1409-11. PubMed ID: 18924320
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori and nonsteroidal antiinflammatory drugs: partners in crime?
    Jones NL; Sherman P; Wang B; Inman RD
    Bull Rheum Dis; 1997 Dec; 46(8):6-8. PubMed ID: 9409058
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agents.
    Cameron C; VAN Zanten SV; Skedgel C; Flowerdew G; Moayyedi P; Sketris I
    Aliment Pharmacol Ther; 2010 Jun; 31(12):1354-64. PubMed ID: 20331582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and non-malignant diseases.
    Furuta T; Delchier JC
    Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment and prophylaxis of alimentary tract lesions caused by non-steroid anti-inflammatory drugs].
    Gil J; Wojtuń S
    Pol Merkur Lekarski; 2009 May; 26(155):353-7. PubMed ID: 19606672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].
    Recenti Prog Med; 2009 May; 100(5):277-8. PubMed ID: 19772220
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview of 50 years' progress in upper gastrointestinal diseases.
    Yeomans ND
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S2-4. PubMed ID: 19799693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [When and why should we eradicate the Helicobacter pylori?].
    Perez Perez GI
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():26-7. PubMed ID: 17471851
    [No Abstract]   [Full Text] [Related]  

  • 10. [Security of proton pump inhibitors].
    Martín de Argila de Prados C
    Rev Esp Enferm Dig; 2011 Feb; 103(2):98. PubMed ID: 21366374
    [No Abstract]   [Full Text] [Related]  

  • 11. Proton pump inhibitors and nonsteroidal anti-inflammatory drug-related lower gastrointestinal adverse events.
    Chan FK
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):904-6. PubMed ID: 24703863
    [No Abstract]   [Full Text] [Related]  

  • 12. [Update on current care guidelines. Safe use of non-steroidal anti-inflammatory drugs].
    Karvonen AL; Hakala M; Helin-Salmivaara A; Kankaanranta H; Kivilaakso E; Kunnamo I; Lehtola J; Martio J
    Duodecim; 2009; 125(5):563-4. PubMed ID: 19385345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and risk of upper gastrointestinal bleeding in NSAID users.
    Ibáñez L; Vidal X; Laporte JR
    Am J Gastroenterol; 2008 Oct; 103(10):2658-9. PubMed ID: 18855866
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selection of proton pump inhibitors in polymorbid patients].
    Uspenskiĭ IuP; Pakhomova IG
    Eksp Klin Gastroenterol; 2013; (2):65-71. PubMed ID: 23947166
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enteropathy induced by nonsteroid anti-inflammatory drugs].
    Karateev AE; Nasonova VA
    Ter Arkh; 2004; 76(2):79-82. PubMed ID: 15106423
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastroesophageal reflux disease stimulation of NSAID-associated atrial fibrillation.
    Daniell HW
    Arch Intern Med; 2011 Apr; 171(7):704-5; author reply 705. PubMed ID: 21482851
    [No Abstract]   [Full Text] [Related]  

  • 18. [NSAID-induced gastropathies: problems and ways of their resolutions].
    Tkachenko EI; Uspenskiĭ IuP; Pakhomova IG
    Eksp Klin Gastroenterol; 2006; (6):41-8. PubMed ID: 17612095
    [No Abstract]   [Full Text] [Related]  

  • 19. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting the stomach from the "toxins" of NSAIDS and anti-platelet agents.
    Echelmeyer S; Kanwal F
    Mo Med; 2009; 106(5):343-5. PubMed ID: 19902714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.